MedDataX Logo

Effectiveness of Group Based Schema Therapy in the Treatment of Personality Disorders

NCT ID: NCT00247234

Last Updated: 2017-09-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

90 participants

Study Classification

INTERVENTIONAL

Study Start Date

2004-09-30

Study Completion Date

2015-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study intends to compare the effectiveness of schema therapy with standard psychiatric outpatient care for patients with borderline or avoidant personality disorder.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Personality Disorder, Borderline Avoidant Personality Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

schema therapy

Group Type EXPERIMENTAL

Schema Therapy

Intervention Type BEHAVIORAL

group based schema therapy

standard care

standard psychiatric out-patient care

Group Type ACTIVE_COMPARATOR

standard care

Intervention Type BEHAVIORAL

standard psychiatric out-patient care

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Schema Therapy

group based schema therapy

Intervention Type BEHAVIORAL

standard care

standard psychiatric out-patient care

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Avoidant or Borderline personality disorders

Exclusion Criteria

* Do not speak Scandinavian languages
* Antisocial personality disorder
* Narcissistic personality disorder
* Affective bipolar disorder I
* Schizophrenia
* Mental impairment/organic brain disorder
* Substance dependence
* Planned pregnancy
* Serious somatic illness
* Anorexia Nervosa
Minimum Eligible Age

20 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Norwegian University of Science and Technology

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Are Holen, M.D., Ph.D.

Role: STUDY_CHAIR

Department of Neuroscience, NTNU - Faculty of Medicine, MTFS, NO-7489 Trondheim, Norway

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

St. Olavs Hospital

Trondheim, , Norway

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Norway

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ursula.falkmer+AEA-stolav.no

Identifier Type: -

Identifier Source: org_study_id